ArticleHuman vaccines & immunotherapeutics2025
Development and characterization of a bivalent mRNA vaccine targeting the Delta and Omicron variants of SARS-CoV-2.
Xiao-Chuan Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.